Supplemental vitamin D: Will do no harm and might do good

Nature Reviews Nephrology

Volumn 5, Issue 11, 2009, Pages 614-615

  Cunningham, John ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; VITAMIN; VITAMIN D;

CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SHORT SURVEY; SKELETON; SUN EXPOSURE; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; NOTE; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RENAL OSTEODYSTROPHY;

HUMANS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RENAL OSTEODYSTROPHY; VITAMIN D; VITAMINS;

EID: 70350475250     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.143     Document Type: Short Survey

References (10)

1. Jones, R. The Cripples' Journal vol. 1, no.1 Published by The shropshire Orthopaedic Hospital, Oswestry, england (1924).
2. Holick, M. F. Resurrection of vitamin D deficiency and rickets. J. Clin. Invest. 116, 2062-2072 (2006).
3. Cunningham, J. Post-transplantation bone disease. Transplantation 79, 629-634 (2005).
4. Palmer, S. C. et al. interventions for preventing bone disease in kidney transplant recipients. Cochrane Database of Systematic Reviews, issue 2. Art. no.:CD005015 doi:10.1002/14651858.CD005015.pub3 (2007). (Pubitemid 351805531)
5. Saito, H. et al. Human fibroblast growth factor-23 mutants suppress na+-dependent phosphate co-transport activity and 1á,25- dihydroxyvitamin D3 production. J. Biol. Chem. 278, 2206-2211 (2003).
6. Courbebaisse, M. et al. effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 75, 646-651 (2009).
7. Heaney, R. P. serum 25-hydroxy-vitamin D and the health of the calcium economy. in Nutritional Aspects of Osteoporosis, 2nd edn (eds Burckhardt, P. et al.) 227-244 (san Diego, elsevier, 2004).
8. Hathcock, J. N. Risk assessment for vitamin D. Am. J. Clin. Nutr. 85, 6-18 (2007).
9. London, G. M. et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J. Am. Soc. Nephrol. 18, 613-620 (2007).
10. Walsh, S. B. et al. effect of pamidronate on bone loss after kidney transplantation: a randomized trial. Am. J. Kidney Dis. 53, 856-865 (2009).